LexDanaLexDanabeta
Inventor

Sacha Holland

Inventor
San Francisco, CA, US

Overview

89→
Patents
2002–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 89 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes24%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium11%
C12NMicroorganisms or enzymes2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
C12YEnzymes2%
C07KPeptides1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
Y02ATechnologies for adaptation to climate change1%
PatentTitleYear
11,110,082Tyrosine kinase inhibitors202111,007,1932,4-pyrimidinediamine compounds and their uses202110,851,093Tyrosine kinase inhibitors202010,828,3012,4-pyrimidinediamine compounds and their uses202010,792,282Protein kinase C inhibitors and uses thereof202010,709,7032,4-pyrimidinediamine compounds and their uses202010,682,3502,4-pyrimidinediamine compounds and their uses202010,434,096Tyrosine kinase inhibitors201910,369,1482,4-pyrimidinediamine compounds and their uses201910,314,8402,4-pyrimidinediamine compounds and their uses201910,166,216Substituted triazoles useful as Axl inhibitors201910,130,623Tyrosine kinase inhibitors201810,005,777Protein kinase C inhibitors and uses thereof20189,913,842'2,4-pyrimidinediamine compounds and their uses'20189,913,843'Protein kinase C inhibitors and uses thereof'20189,834,568Kinase inhibitors and their uses20179,732,070'Protein kinase C inhibitors and uses thereof'20179,682,976'Protein kinase C inhibitors and uses thereof'20179,650,391'N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as Axl inhibitors'20179,586,908'2,4-pyrimidinediamine compounds and their uses'20179,566,278'Protein kinase C inhibitors and uses thereof'20179,540,334'2,4-pyrimidinediamine compounds and their uses'20179,499,493'2,4-pyrimidinediamine compounds and their uses'20169,416,112'2,4-pyrimidinediamine compounds and their uses'20169,353,124'Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors'20169,353,126'Substituted triazoles useful as Axl inhibitors'20169,346,765'2,4-pyrimidinediamine compounds and their uses'20169,321,763'Protein kinase C inhibitors and uses thereof'20169,206,161'Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20159,181,222'Protein kinase C inhibitors and uses thereof'20159,173,882'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20159,169,249'Protein kinase C inhibitors and uses thereof'20159,162,989'2,4-Pyrimidinediamine compounds and their uses'20159,156,820'Polycyclic heteroaryl substituted triazoles useful as axl inhibitors'20159,133,133'2,4-pyridinediamine compounds and their uses'20159,096,542'Kinase inhibitors and their uses'20159,079,898'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20159,062,068'Protein kinase C inhibitors and uses thereof'20159,040,550'2,4-pyrimidinediamine compounds and their uses'20159,018,204'2,4-pyrimidinediamine compounds and their uses'20158,933,080'Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors'20158,906,922'Substituted triazoles useful as AXl inhibitors'20148,853,397'2,4-pyrimidinediamine compounds and their uses'20148,835,430'2,4-pyrimidinediamine compounds and their uses'20148,822,685'2,4-pyrimidinediamine compounds and their uses'20148,809,347'Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors'20148,809,364'Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors'20148,796,259'N3-heteroaryl substituted triazoles and N5-heteroaryl substituted triazoles useful as axl inhibitors'20148,741,898'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20148,710,223'Protein kinase C inhibitors and uses thereof'20148,658,669'Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20148,618,331'Polycyclic heteroaryl substituted triazoles useful as axl inhibitors'20138,609,650'Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20138,574,827'Modulators of angiogenesis and tumorigenesis'20138,563,559'Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors'20138,546,433'Axl inhibitors for use in combination therapy for preventing, treating or managing metastatic cancer'20138,492,373'Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20138,431,594'Bridged bicyclic heteroaryl substituted triazoles useful as AXL inhibitors'20138,389,557'Triazole derivatives useful as Axl inhibitors'20138,349,838'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20138,288,382'Diaminothiazoles useful as Axl inhibitors'20128,168,636'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20128,097,630'Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors'20128,053,434'Kinase inhibitors and their uses'20118,012,965'Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors'20117,935,693'Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20117,884,119'Triazole derivatives useful as Axl inhibitors'20117,879,856'Diaminothiazoles useful as Axl inhibitors'20117,872,000'Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as Axl inhibitors'20117,820,819'2,4-pyrimidinediamine compounds and their uses'20107,709,482'Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors'20107,655,797'Intermediates for making 2,4-pyrimidinediamine compounds'20107,642,351'2,4-Pyrimidinediamine compounds and their uses'20107,601,713'Kinase inhibitors and their uses'20097,589,200'5-Fluoro-4N-phenyl-4-pyrimidineamine compounds'20097,566,546'Modulators of angiogenesis and tumorigenesis'20097,557,210'2,4-pyrimidinediamine compounds and their uses'20097,550,460'2,4-pyrimidinediamine compounds and their uses'20097,527,936'Modulators of angiogenesis'20097,498,435'2,4-pyrimidinediamine compounds and their uses'20097,485,724'2,4-pyrimidinediamine compounds and their uses'20097,485,414'Modulators of angiogenesis'20097,435,814'2,4-Pyrimidinediamine compounds and their uses'20087,419,779'Modulators of angiogenesis'20087,332,484'2,4-pyrimidinediamine compounds and their uses'20087,329,671'2,4-pyrimidinediamine compounds and their uses'20087,329,672'2,4-pyrimidinediamine compounds and their uses'20087,060,827'Intermediates useful for making 2,4-pyrimidinediamine compounds'20066,413,730'Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002Based in Toronto, CA· patent location history
2006–2021Patents assigned to RIGEL PHARMACEUTICALS INC (88)· patent assignee history
2006–2021Based in San Francisco, CA, US· patent location history
2012–2017Patents assigned to HOLLAND SACHA (23)· patent assignee history
2012–2020Patents assigned to SINGH RAJINDER (21)· patent assignee history
2012–2017Patents assigned to GOFF DANE (14)· patent assignee history
2012–2017Patents assigned to ZHANG JING (13)· patent assignee history
2019Based in San Bernardino, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RIGEL PHARMACEUTICALS INC882006–2021
HOLLAND SACHAself232012–2017
SINGH RAJINDER212012–2020
GOFF DANE142012–2017
ZHANG JING132012–2017
Locations
LocationPatentsSpan
San Francisco, California, US872006–2021
San Bernardino, California, US12019
Toronto, CA12002